FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386742626> ?p ?o ?g. }

• W4386742626 abstract "It is estimated that around 30% of the population living in Western countries has metabolic dysfunction-associated steatotic liver disease (MASLD), a spectrum of pathology (not attributed to alcohol/substance intake) initiated by steatosis and progression toward inflammation and irreversible fibrosis metabolic dysfunction-associated steatohepatitis (MASH). With inflammation being a key component of the transition to MASH, it raises the question of whether the ongoing COVID-19 pandemic, which has notoriously induced hyperinflammatory states, may influence the progression of MASLD. Specifically, it remains unclear if the potential chronic sequelae of COVID-19 in patients who recovered from it may increase the predisposition for MASH. Since MASH maintains a high risk for hepatocellular carcinoma, liver failure, and the need for a liver transplant, the potential additive effects of COVID-19 could prove critical to study. Thus, the objective of this study was to conduct a literature review to examine if COVID-19 could have chronic sequelae that affect the progression of MASLD pathogenesis. It was hypothesized that severe cases of COVID-19 could induce systemic inflammation, metabolic changes, and lasting gut microbiome alterations that lead to inflammatory and fibrotic changes in the liver, similar to those seen in MASH. A scoping review of the literature was conducted utilizing the PubMed database. Studies that examined hepatobiliary pathology, gut microbiome, systemic inflammation, metabolic changes, drug-induced liver injury (DILI), and hypoxia seen in COVID-19 were included. Human studies of adult cohorts, animal models, and in vitro experiments were included. Genetic components of MASLD were not examined. Exclusion criteria also encompassed any studies not referencing the hepatobiliary, gastrointestinal tract, portal system, or systemic circulation. Findings indicated a frequent trend of elevated liver enzymes, mild steatosis, Kupffer cell hyperplasia, and hepatobiliary congestion. It was found that direct cytopathic effects on hepatocytes were unlikely, but the direct viral insult of cholangiocytes was a potential complication. High serum levels of IL-1, TNF-a, and MCP-1, in COVID-19 were found as potential risk factors for MASH development. Hypoxia, altered lipid metabolism, and iatrogenic DILI were also proposed as potential precipitators of MASH development. Notably, lasting changes in gut microbiome were also frequently observed and correlated closely with those seen in MASH." @default.
• W4386742626 created "2023-09-15" @default.
• W4386742626 creator A5037937436 @default.
• W4386742626 creator A5051395819 @default.
• W4386742626 date "2023-09-14" @default.
• W4386742626 modified "2023-10-18" @default.
• W4386742626 title "The Lasting Effects of COVID-19 on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)" @default.
• W4386742626 cites W1984916935 @default.
• W4386742626 cites W1985592156 @default.
• W4386742626 cites W2009888551 @default.
• W4386742626 cites W2135356216 @default.
• W4386742626 cites W2257297310 @default.
• W4386742626 cites W2515006541 @default.
• W4386742626 cites W2556576707 @default.
• W4386742626 cites W2593684862 @default.
• W4386742626 cites W2765713881 @default.
• W4386742626 cites W2803483268 @default.
• W4386742626 cites W2883966014 @default.
• W4386742626 cites W2911082440 @default.
• W4386742626 cites W2924281947 @default.
• W4386742626 cites W2955615964 @default.
• W4386742626 cites W3001118548 @default.
• W4386742626 cites W3007122167 @default.
• W4386742626 cites W3008186167 @default.
• W4386742626 cites W3008394341 @default.
• W4386742626 cites W3009834387 @default.
• W4386742626 cites W3015221761 @default.
• W4386742626 cites W3015252146 @default.
• W4386742626 cites W3016151265 @default.
• W4386742626 cites W3016923936 @default.
• W4386742626 cites W3024312732 @default.
• W4386742626 cites W3024705102 @default.
• W4386742626 cites W3029748322 @default.
• W4386742626 cites W3029895132 @default.
• W4386742626 cites W3035546072 @default.
• W4386742626 cites W3037894931 @default.
• W4386742626 cites W3040969871 @default.
• W4386742626 cites W3044264576 @default.
• W4386742626 cites W3092183553 @default.
• W4386742626 cites W3104434004 @default.
• W4386742626 cites W3112440455 @default.
• W4386742626 cites W3113453443 @default.
• W4386742626 cites W3117903539 @default.
• W4386742626 cites W3118579072 @default.
• W4386742626 cites W3120840778 @default.
• W4386742626 cites W3131246465 @default.
• W4386742626 cites W3144414218 @default.
• W4386742626 cites W3154897461 @default.
• W4386742626 cites W3155089717 @default.
• W4386742626 cites W3155464030 @default.
• W4386742626 cites W3157150475 @default.
• W4386742626 cites W3167790110 @default.
• W4386742626 cites W3169035284 @default.
• W4386742626 cites W3188624255 @default.
• W4386742626 cites W3196066729 @default.
• W4386742626 cites W4210900209 @default.
• W4386742626 cites W4212825088 @default.
• W4386742626 cites W4288692567 @default.
• W4386742626 cites W4293446436 @default.
• W4386742626 cites W4307164692 @default.
• W4386742626 cites W4311223008 @default.
• W4386742626 cites W4315874640 @default.
• W4386742626 doi "https://doi.org/10.7759/cureus.45231" @default.
• W4386742626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37842470" @default.
• W4386742626 hasPublicationYear "2023" @default.
• W4386742626 type Work @default.
• W4386742626 citedByCount "0" @default.
• W4386742626 crossrefType "journal-article" @default.
• W4386742626 hasAuthorship W4386742626A5037937436 @default.
• W4386742626 hasAuthorship W4386742626A5051395819 @default.
• W4386742626 hasBestOaLocation W43867426261 @default.
• W4386742626 hasConcept C126322002 @default.
• W4386742626 hasConcept C142724271 @default.
• W4386742626 hasConcept C143121216 @default.
• W4386742626 hasConcept C203014093 @default.
• W4386742626 hasConcept C2776175330 @default.
• W4386742626 hasConcept C2776914184 @default.
• W4386742626 hasConcept C2777075537 @default.
• W4386742626 hasConcept C2777214474 @default.
• W4386742626 hasConcept C2778019345 @default.
• W4386742626 hasConcept C2778772119 @default.
• W4386742626 hasConcept C2779102576 @default.
• W4386742626 hasConcept C2779134260 @default.
• W4386742626 hasConcept C2779478299 @default.
• W4386742626 hasConcept C2780559512 @default.
• W4386742626 hasConcept C2908647359 @default.
• W4386742626 hasConcept C60644358 @default.
• W4386742626 hasConcept C71924100 @default.
• W4386742626 hasConcept C86803240 @default.
• W4386742626 hasConcept C99454951 @default.
• W4386742626 hasConceptScore W4386742626C126322002 @default.
• W4386742626 hasConceptScore W4386742626C142724271 @default.
• W4386742626 hasConceptScore W4386742626C143121216 @default.
• W4386742626 hasConceptScore W4386742626C203014093 @default.
• W4386742626 hasConceptScore W4386742626C2776175330 @default.
• W4386742626 hasConceptScore W4386742626C2776914184 @default.
• W4386742626 hasConceptScore W4386742626C2777075537 @default.
• W4386742626 hasConceptScore W4386742626C2777214474 @default.
• W4386742626 hasConceptScore W4386742626C2778019345 @default.
• W4386742626 hasConceptScore W4386742626C2778772119 @default.

• next